Clinical Challenges: Quadruplet Therapy in Multiple Myeloma

(MedPage Today) -- Will quadruplet therapy become the standard induction therapy for newly diagnosed multiple myeloma?
Currently, standard induction therapy in the U.S. for the disease is a triple therapy of lenalidomide (Revlimid), bortezomib...